Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Non-Current Debt: 2019-2021

Historic Non-Current Debt for Pharming Group N.V (PHAR) over the last 3 years, with Dec 2021 value amounting to $165,000.

  • Pharming Group N.V's Non-Current Debt fell 62.95% to $143,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $143,000, marking a year-over-year decrease of 62.95%. This contributed to the annual value of $165,000 for FY2021, which is 22.17% down from last year.
  • Per Pharming Group N.V's latest filing, its Non-Current Debt stood at $165,000 for FY2021, which was down 22.17% from $212,000 recorded in FY2020.
  • Pharming Group N.V's 5-year Non-Current Debt high stood at $19.4 million for FY2019, and its period low was $165,000 during FY2021.
  • Over the past 3 years, Pharming Group N.V's median Non-Current Debt value was $212,000 (recorded in 2020), while the average stood at $6.6 million.
  • Data for Pharming Group N.V's Non-Current Debt shows a maximum YoY tumbled of 98.91% (in 2020) over the last 5 years.
  • Pharming Group N.V's Non-Current Debt (Yearly) stood at $19.4 million in 2019, then crashed by 98.91% to $212,000 in 2020, then fell by 22.17% to $165,000 in 2021.